Any one remember Eric talking about this in last CC ? Here is the nano cap company that did some P1 trial and now doing a P3 (yes it is P3 trial) which started in Feb 2016 and they have 33 sites up and running in ~10 months While our incompetent Eric and others throwing trash cans at us giving all BS excuses for melanoma P3 trial and P1 liver cancer trials....
https://finance.yahoo.com/news/outcomes-data-using-delcaths-melphalan-130000927.html
https://clinicaltrials.gov/ct2/show/NCT02678572?term=Melphalan/HDS&rank=3
This trial PI is Jonathan Zager, MD Moffitt Cancer Center familiar face for PVCT investors
http://delcath.com/sec-filings/